Professional Documents
Culture Documents
2006
DIABETES MELITUS
Stroke 5X
Amputasi 27.7X
Hyperglycaemia
Increased hepatic
glucose production Decreased
muscle glucose
uptake
DIAGNOSIS
• Pemeriksaan darah
- FBS , RBS , MGTT
• Gejala – gejala diabetes
DIAGNOSTIC CRITERIA FOR
DIABETES (75 G ORAL GLUCOSE
TOLERANCE TEST)
Fasting Plasma < 6.1 Normal
Glucose (mmol/l)
> 6.1 - < 7.0 Impaired Fasting
Glucose
> 7.0 Diabetes
PRIMARY SECONDARY
Type 1 Type 2
(IDDM) (NIDDM)
TYPE 1 VS TYPE 2
• Younger: Age< 30 yrs • Older onset
• Lean • Overweight
• HLA DR3 or DR4 • No HLA links
• Autoimune disease. • No immune
• Present of Islet cell disturbance
antibodies. • Insulin resistance.
• Insulin deficiency. • Partial insulin def.
• May devel. • May devel.
Ketoacidosis. Hyperosmolar state.
• Always need insulin. • 50% need insulin after
• Dissapearance of C- many years.
peptide. • C- peptide persist.
COULD DIABETES
PREVENTED ?????
• Lifestyle modification;
– Weight loss >5%.
– Reduce fat and increase dietary fibre .
– Exercise > 30 min daily.
microvascul macrovascular
ar
CAD, PVD
CVA
KOMPLIKASI DIABETES
AKUT KRONIK
KOMPLIKASI
AKUT
Rosak Rosak
Salurdarah kecil Salurdarah besar
Mata Jantung
Buah pinggang Salur darah anggota
Saraf
Kaki diabetes
DIABETIC COMPLICATIONS
RETINOPATHY
NEPHROPATHY
NEUROPATHY
DIABETIC FOOT
CARDIOVASCULAR DISEASE
MATA
RETINOPATHY
NEPHROPATHY
NEUROPATHY
DIABETIC FOOT
CARDIOVASCULAR DISEASE
Diabetic Nephropathy-
Natural History
Screening for Diabetic
Nephropathy
DARAH TINGGI
DIABETIC COMPLICATIONS
TREATMENT
RETINOPATHY
NEPHROPATHY
NEUROPATHY
DIABETIC FOOT
CARDIOVASCULAR DISEASE
SARAF
Diabetic control
Treat pain/parassthesia
footcare
TYPES OF NEUROPATHY
• PERIPHERAL NEUROPATHY
- Distal Symmetrical
Polyneuropathy
- Mononeuritis ( Amyotrophy )
- Painful Neuropathy ( Acute )
• AUTONOMIC NEUROPATHY
- Gastroperesis, ED, Diabetic
Diarrhoea
Neuropathic Bladder, etc
NEUROPATHY
TREATMENT
PERIPHERAL NEUROPATHY
SYMPTOMATICS
ANTIEPILEPTICS :
Clonoazepam, Gabapentin,
Carbamazipine
TRICYCLICS :
Amitriptyline, Imipramine
OTHERS :
Pentoxifylline, TENS, Acupuncture
TREATMENT
AUTONOMIC DYSFUNCTION
SEXUAL DYSFUNCTION
GASTROPERESIS
SEXUAL DYSFUNCTION
SEXUAL DYSFUCTION
VASCULAR HORMONAL
NEUROLOGIC ASSESSMENT
ASSESSMENT
ASSESSMENT
TREATMENT
I/CAVERNOSAL
HORMONAL INJ PENILE
PI PROTHESIS
NON HORMONAL VACUUM
DIABETIC COMPLICATIONS
RETINOPATHY
NEPHROPATHY
NEUROPATHY
DIABETIC FOOT
CARDIOVASCULAR DISEASE
DIABETIC FOOT
DM NEUROPATHY
PVD PERIPHERAL
ULCER AUTONOMIC
TREATMENT INFECTION
W OUND DEBRID GANGRANE
ANTIBIOTICS PREVENTION
AVOID WT BEARING
REVASCULAR SURGERY OPTIMAL GLYCEMIA
ANTIPLATELET GOOD FOOT CARE
PENTOXYFYLINE FOOT EVALUATION
AMPUTATION PODIATRIC VISIT
DIABETIC FOOT
Screening
Pemeriksaan kaki
6 -12 M
DM control
Specific intensive care
• Common presentation:
• a) Infection
• b) Gangrene
• c) Skin ulcers
• d) Neuropathic joint disorder
( Charcot fracture).
PATHOPHYSIOLOGY
• MULTIFACTORIAL:
• a) Diabetic neuropathy
• b) Vascular disease
• c) Susceptibility to infection
• d) Trauma
• All these predispose the diabetic foot
to ulcerations.
WHY ALL THE FUSS ABOUT
FOOT IN DIABETES
MELLITUS?
• Although the various system failures
associated with DM are more life
threatening, it is noted that diabetic
foot ulcer is more emotional and
more disabling
Risiko amputasi 15X lebih
tinggi untuk pesakit
diabetes berbanding
dengan orang lain.
EVALUATION OF ULCERS
• Hospitilazation.
• Wound debridement/ aggressive.
• Wound care and IV antibiotics.
• Goal to correct to Grade 1 ulcer.
TREATMENT
• Emergency drainage.
• Wound left open for daily dressing till
definite closure.
• IV antibiotic
• If failed, amputation.
TREATMENT
AMPUTATION
TREATMENT
AMPUTATION
Foot ulcer
Foot ulcer
DIABETIC COMPLICATIONS
RETINOPATHY
NEPHROPATHY
NEUROPATHY
DIABETIC FOOT
CARDIOVASCULAR DISEASE
PENYAKIT MACROVASCULAR
SARINGAN CARDIOVASCULAR
YEARLY / GEJALA
CHECK BP
CAROTID BRUIT
PERPHERAL PULSE
SILENT HT
ISCHAEMIA
INSULIN
CARDIO VASCULAR
RESISTANCE
MYOPATHY DYSFUNCTION
HYPER
AMI GLYCAEMIA
CLOTTING ABN
ANGINA SMOKING DYSLIPID-
OBESE AEMIA
CV COMPLICATIONS
3 2.7
2
1.4
0
Normal glucose IGT (n = 690) Newly diagnosed
tolerance (n = 6055) + known diabetes
(n = 293)
Adapted from Eschwege E et al. Horm Metab Res Suppl 1985; 15: 41–6.
infarction (MI) in subjects
with and without diabetes
Diabetics must
7-year follow-up
45 Be treated as if have
Fatal or non-fatal MI incidence
45
40
Had heart attacks
during follow-up (%)
35
30
25 18.8 20.2
20
15
10 3.5
5
0
Prior MI No MI Prior MI No MI
Non DM DM
Haffner SM et al. N Engl J Med 1998;339:229–34
CORONARY ARTERY
DISEASE
TREATMENT
MEDICAL
INVASIVE/SURGICAL
PREVENTION
MEDICAL TREATMENT
THROMBOLYTIC THERAPY
ANTIPLATELET
BETA BLOCKER
ACE INHIBITOR
TIGHT GLYCAEMIC CONTROL
CORRECT CVS RISK FACTORS
INVASIVE/SURGICAL
PERCUTANEOUS CORONARY
INTERVENTION ( PCI )
ANGIOPLASTY +/- STENTING
SURGICAL BYPASS ( CABG )